APS provides cutting-edge self-injectable therapies to manage complex disease states, helping patients live more normal lives. We closely monitor our patients’ adherence and early signs of adverse drug events (ADEs) to prevent hospitalizations.

APS has been dedicated to preventing Respiratory Syncytial Virus (RSV) in qualified babies since 2001. Our commitment to our local California communities has grown us to the #1 Medi-Cal provider of Synagis®. Our proprietary Synagis® Management.

APS’ Respiratory Programs provide unique continuums of care for each complex patient’s needs. Our Respiratory Therapists focus on early interventions to prevent hospital re-admissions.

APS understands that family support is the keystone to completing a successful homecare therapy. While our mission is dedicated to providing the most cost-effective homecare modalities, caring for patients and their family is what we really do.